X

AggregoTV

Top Stories
ESMO Vision stories of Integrated Cancer Care: Verna Vanderpuye, Ghana

"I think ESMO is poised to do that and I think we have a bright future ahead of us," says ESMO member Verna Vanderpuye from Ghana.

10/23/2020
What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

12/14/2020

AggregoTV

`
ESMO Vision Stories of Sustainable Cancer Care: Andrea Sbrana

Is statistically significant the same as clinically significant? The ESMO-MCBS has been thought to try and answer this question even when talking about newer treatments, explains Andrea Sbrana.

12/17/2020
What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

12/14/2020
Leukemia, Lymphoma, Myeloma, and Immunotherapy with Dr. Philip Greenberg

Dr. Philip Greenberg discusses how immunotherapy works for blood cancers, promising immunotherapy clinical trials, as well as potential side effects.

12/11/2020
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

12/11/2020
Pancreatic Cancer and Immunotherapy with Dr. Elizabeth M. Jaffee

Join Dr. Elizabeth Jaffee of the Bloomberg~Kimmel Institute for Cancer Immunotherapy for a Q&A discussion about immunotherapies in clinical trials for pancreatic cancer.

12/11/2020

AggregoTV - AML

Understanding Risk in AML: How Molecular Testing Affects Treatment Options

How does molecular testing impact AML treatment options? Dr. Pinkal Desai discusses molecular testing and how results may help determine the best treatment path for patients.

11/19/2020
What Are the Goals of AML Treatment?

Dr. Pinkal Desai defines the role of remission and the specific goals of treatment for AML patients.

11/19/2020
An update on the NCRI AML20 trial

Charles Craddock describes the three main questions the trial aims to address, including whether the addition of venetoclax can improve the activity of CPX-351 in adults with AML.

10/21/2020
What is new in targeted therapies for AML?

Dr. Navel Daver discusses the use of single agents, such as the FLT3 inhibitor, gilteritinib, and the IDH1 inhibitor, ivosidenib, as well as the outcomes of more recent combination treatments with

10/19/2020
Choosing an AML Treatment Path: What Should You Consider?

What should be considered when choosing an AML treatment path? Dr. Pinkal Desai explains the factors that are considered to determine the best treatment for an individual patient.

11/19/2020
Is HSCT an option for refractory AML?

During the 3rd Annual Meeting of the IACH, the AML Hub was pleased to speak to Mohamad Mohty, Hôpital Saint-Antoine and Sorbonne University, Paris, FR.

09/30/2020

AggregoTV - NSCLC

Personalized Medicine, Genetic Testing Could Shape the Future of Non-Small Cell Lung Cancer

According to Dr. Nathan A.

09/09/2020
LungART: Radiotherapy after Surgery for Patients with Non Small Cell Lung Cancer

Dr Cécile Le Péchoux talked to ecancer online about the LungART trial presented at the ESMO 2020 virtual meeting this year.

10/07/2020
COVID-19: Management of Non-Small Cell Lung Cancer Patients During the Coronavirus Pandemic

 

Dr Heather Wakelee from the University of Stanford speaks to ecancer about the treatment of NSCLC patients during the COVID-19 pandemic.

11/20/2020
Lung Cancer Immunotherapy with Dr. Leena Gandhi

Dr. Leena Gandhi leads a discussion on the latest immunotherapy for lung cancer patients.

10/09/2020
PD-L1 Testing in Non-Small Cell Lung Carcinoma

Dr. Anja Roden discusses the role of PD-L1 interaction in the immune system, challenges with PD-L1 testing, and current PD-L1 testing in NSCLC.

11/05/2020
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer

Prof. Fabrice Barlesi speaks to ecancer about the ESMO 2020 virtual congress concerning a first analysis of the PIONeeR study.

11/13/2020
Spotlight
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

12/11/2020

source list reference

#7d60d9
#2694a4
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#42fc9a
#cc529a
#c59445
#c8cc0c
#e8085a
#97d1a0
#b61f77
#a153ac
#e7f6e3
#9a8c2c
#a9c507
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#49cde9
#c20fce
#d95d39